Guangzhou Baiy | 600332 - Cost Of Sales


Guangzhou Baiy reported CNY16.27B in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Aspen Pharmacare ZAR 9.63B 3.1B Dec/2025
Cipla INR 29.71B 3.4B Jun/2026
Dr.Reddys Laboratories INR 39.22B 1.52B Jun/2026
Jiangsu Hengrui CNY 1.02B 68.56M Jun/2026
Kalbe Farma IDR 6.01T 554.92B Mar/2026
Richter Gedeon HUF 72.45B 1.13B Mar/2026
Sh Fosun Pharma CNY 5.22B 154.71M Jun/2026
Sh Pharmaceutical CNY 64.04B 3.13B Jun/2026
Sun Pharmaceuticals INR 37.02B 9.01B Jun/2026
Teva Pharmaceutical Industries USD 1.98B 30M Jun/2026